Skip to content
Medicines & Healthcare products Regulatory Agency
The National Institute for Biological Standards and Control

Confidence in biological medicines

  • Stay connected
  • Shopping Basket
  • Pay Now
  • Login / Register
  • Home
  • Products
  • Standardisation
  • Control testing
  • Science and research
  • Expert services
  • About us
  • Latest news
  • Worldwide impact of NIBSC
  • Mission and values
  • Careers
  • Quality and governance
  • Staff profiles
  • Contact us
  • Collaborations
  • Suppliers
  • Scientific Advisory Committee
  • Minutes of the Animal Welfare and Ethical Review Body
  • Our use of animals
  • Privacy notice
  • Home  /  
  • About us  /  
  • Latest news  /  
  • New QCRU CE-marked Measles, Mumps and Lyme disease run controls

New  CE-marked measles, mumps and Lyme disease run controls

16 November 2015

To complement the 32 QCRU serology reagents currently CE-marked, we are pleased to announce a further 4 CE-marked reagents produced in response to customer requests.

To aid in the diagnosis of measles (anti-measles IgG), mumps (anti-mumps IgG) and Lyme disease (anti-Lyme IgM and anti-Lyme IgG), these run controls are designed to assure the quality of results obtained during testing of clinical diagnostic serology samples and are suitable for all major automated diagnostic serology platforms as well as most manual assays.

For more information email enquiries@nibsc.org.

 
 
 
  • Careers
  • Terms and conditions
  • Accessibility
  • Privacy notice
  • Cookies
  • Sitemap